GLP-1 drug stocks slumped today after President Trump signaled plans to drive down the price of at least one of the blockbuster weight-loss and diabetes treatments.
Why it matters: GLP-1 drugs remain cost prohibitive for many Americans as Medicare and many private insurance plans don't cover them for weight loss purposes.
President Trump on Friday confirmed a U.S. military strike on an alleged "drug-carrying submarine" in the Caribbean.
Why it matters: Thursday's attack is the first known instance of the U.S. capturing survivors from a suspected drug-carrying vessel from Venezuela, multipleoutlets reported.
The Food and Drug Administration on Thursday selected nine drugs for expedited reviews intended to speed up the approval process.
Why it matters: The awarding of the new priority review vouchers is a key focus of FDA commissioner Marty Makary, who has called for shaking up how the agency handles drug approvals that can take up to a year.
The White House on Thursday announced measures aimed at expanding access to in vitro fertilization, including a new "most-favored nation" pricing deal with the manufacturer of a leading fertility drug.
Why it matters: The effort combines two Trump priorities: lowering drug prices and making IVF treatment more affordable.
WeightWatchers is emerging from bankruptcy with a plan to "radically evolve," new CEO Tara Comonte tells Axios.
Why it matters: The company, long synonymous with its calorie-counting points system, is fighting to stay trusted — and profitable — in an era of telehealth startups, buzzy weight-loss meds and women's health innovation.
LGBTQ+ youth anxiety and depression symptoms, as well as suicidal ideation, rose over the course of a year, according to a Trevor Project report published Thursday.
Why it matters: The survey charted youth well-being before, during and after the presidential election, as President Trump has targeted LGBTQ+ rights since his inauguration.
Americans who say the U.S. is less healthy under the leadership of President Trump and Health Secretary Robert F. Kennedy Jr. now outnumber believers 2-to-1, per the latest Axios-Ipsos American Health Index.
The big picture: Skepticism over child vaccine requirements has ticked up since Trump took office in January, while Americans' trust in the Centers for Disease Control and Prevention, National Institutes of Health and Food and Drug Administration is declining.
A key measure of CEO confidence dipped slightly lower into negative territory, according to a survey of executives out Thursday morning.
About two-thirds said they expect stagflation over the next year and a half.
Why it matters: It's a sign of the uncertain business environment — as leaders grapple with a constantly changing policy landscape, particularly around tariffs.
